Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review

被引:36
作者
Fattizzo, Bruno [1 ]
Zaninoni, Anna [1 ]
Giannotta, Juri A. [1 ]
Binda, Francesca [1 ]
Cortelezzi, Agostino [1 ,2 ]
Barcellini, Wilma [1 ]
机构
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Oncohematol, Via F Sforza 35, I-20100 Milan, Italy
[2] Univ Milan, I-20122 Milan, Italy
关键词
Immune thrombocytopenia; Autoimmune hemolytic anemia; Chronic idiopathic neutropenia; Vitamin D; Vitamin D receptor; Immunomodulatory cytokines; RISK MYELODYSPLASTIC SYNDROMES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; D DEFICIENCY; HEMOLYTIC-ANEMIA; RETINOIC ACID; PHASE-II; 1-ALPHA-HYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; MULTIPLE-MYELOMA; DIFFERENTIATION;
D O I
10.1016/j.autrev.2016.03.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vitamin D deficiency is widespread in Western Countries and has been found related to autoimmune and hematologic disease incidence and clinical course. We evaluated vitamin D levels, vitamin D receptor (VDR) and T helper (Th)1, Th2 and Th17 immunomodulatory cytokines in patients with immune thrombocytopenic purpura (ITP, N = 44), primary autoimmune hemolytic anemia (AIHA, n = 35), Evans' syndrome (n = 5) and chronic idiopathic neutropenia (ClN, n = 19) and also tested vitamin D effect on the in vitro production of anti-erythrocyte autoantibodies. 25-OH-vitamin D levels were significantly lower and vitamin D receptor higher in patients than in controls. Among ITP cases, those with very low vitamin D levels displayed reduced platelet counts, irrespective of the bleeding history. In AIHA patients, LDH values negatively correlated with vitamin D levels in mixed forms, and reticulocyte counts were positively related with vitamin D. Considering treatment, AIHA patients who had been treated with 2 therapy lines or more showed lower mean 25-OH-vitamin D levels than those untreated or treated with one line of therapy only. IL-6, IL-10, IL-17 and IFN-gamma levels were higher in patients versus controls, whereas TNF-alpha. was significantly reduced. Finally, vitamin D at concentrations of 10, 20, and 40 ng/mL reduced the in vitro production of anti-erythrocyte autoantibodies both in pokeweed-stimulated and unstimulated cultures, In conclusion, vitamin D is reduced in autoimmune cytopenias and correlate with disease severity, supporting its possible protective role against the development of autoimmunity. Literature review showed vitamin D deficiency reports both in onco- and in non onco-hematologic diseases with a relationship with disease severity/activity in myeloid and lymphoid neoplasms, as well as in sickle cell disease. Supplementation has produced weak results in autoimmune and hematologic diseases, and further studies are needed. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:770 / 775
页数:6
相关论文
共 44 条
[1]   Multicenter phase II trial of vitamin K2 monotherapy and vitamin K2 plus 1α-hydroxyvitamin D3 combination therapy for low-risk myelodysplastic syndromes [J].
Akiyama, Nobu ;
Miyazawa, Keisuke ;
Kanda, Yoshinobu ;
Tohyama, Kaoru ;
Omine, Mitsuhiro ;
Mitani, Kinuko ;
Ohyashiki, Kazuma .
LEUKEMIA RESEARCH, 2010, 34 (09) :1151-1157
[2]  
Atkinson SA, 1998, INT J CANCER, V78, P35
[3]   Prevalence and significance of vitamin D deficiency in multiple myeloma patients [J].
Badros, Ashraf ;
Goloubeva, Olga ;
Terpos, Evangelos ;
Milliron, Todd ;
Baer, Maria R. ;
Streeten, Elizabeth .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (03) :492-494
[4]  
Barcellini W, 2003, BRIT J HAEMATOL, V111, P452
[5]   RETINOIC ACID IN MONO OR COMBINED DIFFERENTIATION THERAPY OF MYELODYSPLASIA AND ACUTE PROMYELOCYTIC LEUKEMIA [J].
BLAZSEK, I ;
FARABOS, C ;
MUSSET, M ;
GOLDSCHMIDT, E ;
COMISSO, M ;
BENAVIDES, M ;
WANG, ZY ;
LABAT, ML ;
MATHE, G ;
MISSET, JL .
BIOMEDICINE & PHARMACOTHERAPY, 1991, 45 (4-5) :169-177
[6]   Refractory immune thrombocytopenia successfully treated with high-dose vitamin D supplementation and hydroxychloroquine: Two case reports [J].
Bockow B. ;
Kaplan T.B. .
Journal of Medical Case Reports, 7 (1)
[7]   Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation [J].
Chen, Sheng ;
Sims, Gary P. ;
Chen, Xiao Xiang ;
Gu, Yue Ying ;
Chen, Shunle ;
Lipsky, Peter E. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (03) :1634-1647
[8]   1,25-Dihydroxyvitamin D3 Modulates Th17 Polarization and Interleukin-22 Expression by Memory T Cells From Patients With Early Rheumatoid Arthritis [J].
Colin, E. M. ;
Asmawidjaja, P. S. ;
van Hamburg, J. P. ;
Mus, A. M. C. ;
van Driel, M. ;
Hazes, J. M. W. ;
van Leeuwen, J. P. T. M. ;
Lubberts, E. .
ARTHRITIS AND RHEUMATISM, 2010, 62 (01) :132-142
[9]   Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? [J].
D'Aurizio, Federica ;
Villalta, Danilo ;
Metus, Paolo ;
Doretto, Paolo ;
Tozzoli, Renato .
AUTOIMMUNITY REVIEWS, 2015, 14 (05) :363-369
[10]   Role of vitamin D in acquired immune and autoimmune diseases [J].
Delvin, Edgard ;
Souberbielle, Jean-Claude ;
Viard, Jean-Paul ;
Salle, Bernard .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2014, 51 (04) :232-247